Sunday Apr 13
The San Diego Union-Tribune
Partner at Domain seeks out innovators
Kim Kamdar of Domain Associates says the company is excited about biotech and medical device companies in the effort to tailor medicine to specific patients.
AstraZeneca's New Diabetes Drug May Also Combat Alzheimer's Disease
A relatively new diabetes drug, Symlin , developed by AstraZeneca's Amylin Pharmaceuticals has been found to combat a major component of Alzheimer's disease and may offer a new treatment option for the millions of Americans with the memory-robbing condition.
Novo Nordisk Upgraded to 'Buy'
Novo Nordisk was handed an upgrade to "buy" from "hold" on Tuesday from Austria's Erste Group, helping to boost its shares 1%.
FDA Approves Orphan Drug Myalept
AstraZeneca announced FDA approved orphan drug Myalept , which is indicated as an adjunct to diet as replacement therapy for the treatment of complications of leptin deficiency in patientswith congenital or acquired generalized lipodystrophy.